Kyle M. Kampman, MD | Psychiatrist.com

Depression and Cue Reactivity in Opioid Use Disorder Patients Receiving Extended-Release Naltrexone

Brief Report

Depression and Cue Reactivity in Opioid Use Disorder Patients Receiving Extended-Release Naltrexone

April 17, 2023

Greater depression severity was linked to less reduction in cue-induced craving during naltrexone treatment for OUD.

Zhenhao Shi, Xinyi Li, Kyle M. Kampman, et al

Article

Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence

May 27, 2014

Theresa M. Winhusen, Frankie Kropp, Robert Lindblad, et al